Archives: Speakers

Dan Levy

Dan is  Vice President, Partnerships and Communications at award-winning betting exchange and prediction-market platform Smarkets, which has processed over £10 billion worth of transactions for customers across the company’s licensed and regulated markets. He is based in the London HQ and joined in 2017, overseeing commercial, media and API relationships, as well as company content. His 15-year career spans France and the UK, covering journalism, communications, business development, PR, and marketing – with a decade in the media industry, as well as several years in tech and fashion. Highlights include co-launching a clothing line, creating his own podcast, and running the sports department of an international TV news channel in Paris.

 

 

Evan Wohl

Manage all aspects of the clinical supplies packaging, labeling, storage, distribution and returns accountability process.

Specialties: Clinical Supplies packaging strategies and IRT integration
NJ registered Pharmacist

Anthony Orosz

ANTHONY OROSZ is Assistant Director, Pharmaceutical CEE at Customs and Border Protection.  Mr. Orosz began working for CBP in 1995 as a Customs Inspector at JFK Airport in New York.  During his time at JFK he was a member of the Anti-Terrorism Contraband Enforcement Team and was a National Instructor for Customs and Border Protection.  Mr. Orosz has been with the C-TPAT program since its inception in 2003 and served as a supervisor in the C-TPAT Newark Field Office.  He is now currently assigned as an Assistant Director in the newly established Pharmaceutical, Health and Chemical Center of Excellence and Expertise in New York City

Francis Dumont

I am the Senior Director, External Drug Product Supply Strategy, within Pharmaceutical Sciences Small Molecule (PSSM) at Pfizer. I am currently based in La Jolla, CA following 25 years at the Groton, CT site. My current areas of focus include strategic sourcing, vendor relationship management, and integration process improvement within the clinical drug product manufacturing space.

I joined Pfizer in 1992 and have held several positions within the Pharmaceutical Sciences organization that covered a broad span of responsibilities. These roles have included leadership of global teams and initiatives, accountability for sourcing and manufacturing oversight of development and commercial stage products for clinical trial use, direct facility support for clinical scale sterile manufacturing, external drug delivery technology evaluation and development, as well as formulation development and analytical characterization responsibilities. I have a BS degree in Chemistry from Central Connecticut State University.

Dave Walker

Highly experienced Project Director and Clinical Team Leader with over 30 years’ broad experience in the pharmaceutical industry; spanning both large pharma and small-medium enterprises (SMEs), leading development projects from discovery to lifecycle management in a variety of therapeutic areas.

After an early lab based career with SmithKline & French, worked for 20 years with GlaxoSmithKline seeing that organisation grow from modest beginnings as Glaxo Group Research into GlaxoWellcome, and then GSK, gaining broad experience in respiratory, GI and CNS therapy areas. Highlights including delivery of the migraine products,  Imigran®, and Naraming® to the market in the 1990s, and helping embed the Psychiatry Centre of Excellence for Drug Discovery in the early years of GSK.

After a couple of years experiencing the varied life of an SME working as Clinical Development Director with an Anglo-Japanese pharmacogenomics life sciences company PGXIS, joined Norgine as Therapy Area Director in April 2011.  Helped Norgine transition through a period of organisational change embedding a shift from line to matrix working.  Currently heading the Clinical Development group, with personal responsibilities for line management, GCP, service provider selection and Sponsor oversight.  The role also includes matrix management governance responsibilities for a variety of projects in gastroenterology, hepatology and critical care, with experience including medicinal products, medical devices, diagnostics and advanced therapeutic medicinal products (ATMPs).  Recent highlight seeing PLENVU® gain both EU MAA & US NDA approvals & subsequent launches of the world’s first 1L bowel preparation in 2018.

Outside of work, my wife and 4 children are my most precious concerns, and as the children grow towards independence, tennis is a passion and golf an enigma, both yet to be conquered to any degree of satisfaction!